Amprius Technologies 10-K Report: Detailed Investor Summary

Key Points and Highlights

• Business Overview: Amprius Technologies, Inc. develops, manufactures, and markets disruptive lithium-ion batteries for mobility applications, including aviation, ground, and marine vehicles. The company’s principal executive offices are located in Fremont, California, and its common stock (AMPX) is listed on the New York Stock Exchange. As of February 27, 2026, there were 137,019,004 shares of common stock outstanding. The company had a public float of approximately \$518.4 million as of June 30, 2025 [[16]].
• Forward-Looking Statements: Amprius makes extensive forward-looking statements regarding its business strategy, financial performance, expansion plans, manufacturing capacity, and capital requirements. These statements are subject to significant risks and uncertainties, including the ability to raise capital, expand manufacturing, and maintain customer confidence [[22]].
• Risks and Uncertainties:
  • Amprius is an early-stage company with a history of financial losses, expecting significant expenses and continuing losses for the foreseeable future.
  • The company relies heavily on third-party manufacturers and complex equipment, which introduces risks related to operational performance, cost targets, and supply chain interruptions.
  • There are substantial risks related to global economic, geopolitical, and market conditions, particularly due to sales to customers outside the United States (notably Europe) and exposure to trade tariffs and military conflicts.
  • Customer concentration is high, and any reduction in purchases by key customers or customers in impacted geographies could materially affect revenue.
  • Amprius may require additional capital for growth and manufacturing expansion, and access to financing is not assured. Sudden liquidity issues in financial markets or adverse macroeconomic developments may impact its ability to raise funds.
  • There are risks related to intellectual property protection, product recalls, product liability, and compliance with governmental contracts and regulations.
• Strategic Developments:
  • Amprius expanded its product portfolio with the addition of SiCore in 2024 and invested substantially in new products and enhancements. The company faces risks in resource allocation and potential delays or technical obstacles in developing new battery products and cell formats.
  • Management and Board: Notably, Dr. Kang Sun, Executive Advisor and former CEO, serves on the board of Berzelius, creating potential conflicts of interest.
  • Amprius continues to pursue development agreements and strategic alliances, which may have both positive and negative implications for business growth and risk exposure.
• Financial Reporting and Controls:
  • Amprius is obligated to develop and maintain effective internal controls over financial reporting. The company has not filed a report on internal control attestation under Section 404(b) of Sarbanes-Oxley.
  • Any inability to maintain effective controls may adversely affect investor confidence, stock price, and business operations.
• Market and Shareholder Information:
  • Securities registered: Common stock (\$0.0001 par value, trading symbol AMPX) and redeemable warrants (AMPX.W), both on the NYSE.
  • The company is not a well-known seasoned issuer; it is a non-accelerated filer, a smaller reporting company, and an emerging growth company.
  • Amprius is not a shell company. No restatements or corrections of prior financial statements were required in this report.
  • Sales of substantial amounts of common stock or warrants, or perceptions thereof, could cause the market price to drop significantly.

Potential Price-Sensitive Information for Shareholders

• Expansion and Capital Requirements: Amprius expects to incur significant capital expenditures related to manufacturing expansion and product development. The ability to raise additional funds is uncertain, and failure to secure capital could result in delayed expansion or reduced operations, directly affecting growth prospects and share value.
• Customer and Geopolitical Risks: A notable portion of sales comes from customers outside the U.S., especially Europe. Geopolitical risks, such as tariffs, trade barriers, and military conflicts, could disrupt sales, supply chains, and market opportunities.
• Product Development Risks: Technical delays or inability to meet manufacturing cost targets and customer requirements could adversely affect Amprius’ competitive position, revenue, and profitability.
• Early-Stage Financial Risks: The company is still in early commercial stages, with ongoing operating losses and uncertain revenue growth. Any negative developments or inability to execute its business plan could result in significant share price volatility or loss of value.
• Shareholder Dilution and Liquidity Risks: If Amprius raises additional capital via equity, current shareholders may face dilution. Market-wide liquidity challenges or adverse developments in financial markets could make financing unattractive or unavailable.
• Regulatory and Internal Control Risks: Failure to maintain effective financial controls or compliance with government contracts could materially impact the company’s reputation, investor confidence, and share price.

Conclusion

Amprius Technologies’ 10-K report outlines a company with high growth ambitions but significant risks. Investors should closely monitor developments related to manufacturing expansion, capital raising, customer concentration, geopolitical risks, and technical progress. Any negative developments in these areas could materially impact Amprius’ share value. The company’s status as an early-stage, emerging growth company means volatility and uncertainty are likely to persist.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with a financial advisor before making any investment decisions. The information summarized herein is based on the company’s SEC filings and is subject to change. Amprius Technologies is an early-stage company and faces numerous risks; past performance is not indicative of future results.

View Amprius Technologies, Inc. Historical chart here